Literature DB >> 14709369

The close relationship between postprandial remnant metabolism and insulin resistance.

Jun-ichi Funada1, Michihito Sekiya, Takashi Otani, Kouki Watanabe, Makoto Sato, Hiroshi Akutsu.   

Abstract

The aim of this study was to investigate the relationship between postprandial remnant-like particle (RLP) metabolism and insulin resistance (IR). The study group consisted of 52 randomly selected subjects. To evaluate postprandial hyperlipidemia, serum lipid and lipoprotein concentrations during fasting and 4h after the fat-loading test were measured in each subject. IR was assessed using the index of homeostasis model assessment (HOMA-R). The subjects were divided into two groups according to the value of HOMA-R: an IR group (n=17) with a HOMA-R value >/=1.73, and a normal (NR) group (n=35) with a HOMA-R value <1.73. Both fasting and postprandial RLP-cholesterol (RLP-C) concentrations were higher in the IR group than in the NR group (6.2+/-2.6 versus 4.1+/-1.7mg/dl fasting value, and 9.7+/-4.0 versus 5.8+/-2.9mg/dl postprandial value). The changes in RLP-C concentration during the fat-loading test were twice as high in the IR group compared with the NR group (3.5+/-2.4 versus 1.6+/-1.6mg/dl, P=0.0022). The HOMA-R correlated significantly with both fasting and postprandial triglyceride (r=0.41 and 0.43, respectively) and RLP-C (r=0.36 and 0.50, respectively) in all subjects. Multiple regression analysis indicate that postprandial RLP-C concentration was an independent predictor of HOMA-R regardless of age, BMI, and other lipid profiles. Thus, postprandial RLP metabolism is closely related to IR. Atherosclerotic proliferation in IR syndrome may be caused by the accumulation of postprandial remnant lipoproteins after the daily fat intake.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14709369     DOI: 10.1016/j.atherosclerosis.2003.09.016

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  6 in total

Review 1.  Remnant lipoproteins and atherosclerosis.

Authors:  ThB Twickler; G M Dallinga-Thie; M J Chapman; J S Cohn
Journal:  Curr Atheroscler Rep       Date:  2005-03       Impact factor: 5.113

2.  The role of remnant cholesterol beyond low-density lipoprotein cholesterol in diabetes mellitus.

Authors:  Xiangming Hu; Qunzhi Liu; Xingyuan Guo; Weimian Wang; Bingyan Yu; Beijia Liang; Yingling Zhou; Haojian Dong; Jijin Lin
Journal:  Cardiovasc Diabetol       Date:  2022-06-27       Impact factor: 8.949

3.  Chylomicron remnants are increased in the postprandial state in CD36 deficiency.

Authors:  Daisaku Masuda; Ken-ichi Hirano; Hiroyuki Oku; Jose C Sandoval; Ryota Kawase; Miyako Yuasa-Kawase; Yasushi Yamashita; Masanori Takada; Kazumi Tsubakio-Yamamoto; Yoshihiro Tochino; Masahiro Koseki; Fumihiko Matsuura; Makoto Nishida; Toshiharu Kawamoto; Masato Ishigami; Masatsugu Hori; Iichiro Shimomura; Shizuya Yamashita
Journal:  J Lipid Res       Date:  2008-08-27       Impact factor: 5.922

4.  Remnant Cholesterol is an Independent Predictor of New-Onset Diabetes: A Single-Center Cohort Study.

Authors:  Guobo Xie; Yanjia Zhong; Shuo Yang; Yang Zou
Journal:  Diabetes Metab Syndr Obes       Date:  2021-12-03       Impact factor: 3.168

5.  Pediatric Metabolic Syndrome: Pathophysiology and Laboratory Assessment.

Authors:  Victoria Higgins; Khosrow Adeli
Journal:  EJIFCC       Date:  2017-03-08

Review 6.  Postprandial Hyperlipidemia and Remnant Lipoproteins.

Authors:  Daisaku Masuda; Shizuya Yamashita
Journal:  J Atheroscler Thromb       Date:  2016-11-08       Impact factor: 4.928

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.